Japan ETFs grabbed $19.2B this week. The flow marked 81% buying pressure. The surge reversed three-month trends showing $127B total inflows. US funds absorbed $35.3B weekly as defensive rotation accelerated.
US dominated with $35.3B weekly inflows yet saw just 57% flow imbalance. The muted conviction contrasted with Japan's 81% imbalance. Emerging markets bled $1B weekly reversing three-month gains. India shed $585M after absorbing $223M quarterly. China grabbed $651M weekly amid $95B quarterly outflows showing tentative reversal.
Hong Kong pulled $2.4B weekly with 75% imbalance. Taiwan added $1.3B at 87% imbalance showing strong Asia ex-China conviction. Australia shed $615M as commodity uncertainty persisted. Europe absorbed modest outflows with developed Europe down $318M weekly despite $22.5B quarterly inflows.
Energy grabbed $513M weekly reversing tech bleeding. Information Technology shed $2.5B despite 45% imbalance showing forced liquidation. Materials crashed hardest losing $2.8B at just 15% imbalance. Health Care bled $1.3B with 35% buying pressure.
Industrials dominated three-month flows pulling $23.6B total. The sector reversed weekly shedding $163M. Financials grabbed $391M weekly after flat quarterly performance. Consumer Discretionary added $316M reversing $1.7B quarterly outflows showing reopening rotation.
Equities pulled $66.7B weekly at 59% imbalance. The asset class dominated with $529B quarterly inflows. Fixed income grabbed $8.2B weekly maintaining $229B quarterly momentum. Commodities bled $12.6B weekly reversing $1.7B quarterly outflows.
Vanilla strategies dominated pulling $61.1B weekly at 63% imbalance. Active funds grabbed $6.9B weekly strengthening $134B quarterly inflows. ESG shed $2.1B weekly despite flat quarterly flows. Value strategies bled $1.8B reversing $10.5B quarterly gains. Growth shed $1.2B weekly yet grabbed $9.3B quarterly.
Capital rotated hard into Japan energy and away from US tech materials.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
